CHEMBL217305 [484207]
CHEMBL217305
| SMILES | CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@H](C(N)=O)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C1=O |
| InChIKey | XTNWQOXFVSNCOT-QNWIHAEASA-N |
| Sequence | None |
| HELM | PEPTIDE1{[ac].[Nle].D}|PEPTIDE2{P.F.R.[dW].[dK].[am]}$PEPTIDE1,PEPTIDE2,3:R2-1:R1|PEPTIDE2,PEPTIDE1,5:R3-3:R3$$$ |
Chemical Properties
| Hydrogen bond acceptors | 10 |
| Hydrogen bond donors | 11 |
| Rotatable bonds | 15 |
| Log P | -0.708 |
| Molecular weight (Da) | 983.5 |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
CHEMBL217305
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0